Project Grant HT94252510171
Award Date
9/1/25
Completion Date
8/31/27
Dollars Obligated
$358K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Cincinnati, OH 45220, USA
Similar Awards
The University of Miami received a $1,534,759 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the "RESTORATION OF INNER EAR CELLS IN THE HEARING LOSS-ASSOCIATED HUMAN INNER EAR SYSTEM". This 3-year award, with a period of performance from September 30, 2023 to September 29, 2026, will support the university's biomedical research efforts focused on developing new treatments and...
This $1.42M Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at the University of Miami to prevent hidden hearing loss and synaptopathy following noise overexposure through targeted temperature management. The 3-year grant, awarded on July 15, 2023, will fund this study focused on improving medical solutions for the battlefield and transforming health care for Service Members and the public through...
The U.S. Department of Defense awarded a $350,848 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Regents of the University of Michigan to fund a 2-year research project titled "A Novel Strategy to Prevent Central Auditory Disorders After Blast Exposure." The project aims to develop a nanoparticle-based delivery system to administer therapeutics that can prevent hearing loss and other auditory impairments resulting from blast exposures...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $358,245 Project Grant to the Massachusetts Eye And Ear Infirmary on May 15, 2024 for the project "IN SILICO SCREEN AND IN VIVO EVALUATION OF FDA-APPROVED DRUGS TO TREAT NOISE-INDUCED HEARING LOSS". The grant supports a two-year effort to screen FDA-approved drugs and evaluate the most promising compounds for their ability to protect against noise-induced hearing loss in cell...
This federal Project Grant award of $1,170,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by the Regents of the University of Michigan to develop systemically administered bispecific antibodies that activate neurotrophin receptors for treating noise-induced inner ear damage. The award period runs from May 15, 2025 to May 14, 2028. The Military Medical Research and Development program funds advanced biomedical research...
The U.S. Defense Health Agency awarded a $825,000 Project Grant to Delix Therapeutics, Inc. in Palo Alto, CA under the Military Medical Research and Development program (CFDA 12.420). The funding will support the "DEVELOPMENT OF SMALL-MOLECULE TREATMENT FOR HEARING LOSS" over a 3-year period from June 1, 2024 to May 31, 2027. The Military Medical Research and Development program provides grants to academic institutions, research centers, and medical universities to conduct biomedical...
The federal Project Grant award of $810,000.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research on "EARLY NEUROMODULATION FOR COGNITIVE RECOVERY AND REHABILITATION IN TRAUMATIC BRAIN INJURY" at the University of Cincinnati. The grant, awarded on Nov 1, 2024, with a completion date of Oct 31, 2027, will fund scientific investigations exploring innovative approaches to disease prevention, diagnosis, treatment,...
This $1,561,794 Project Grant was awarded by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant supports research led by the University of Cincinnati to investigate the role of plasmacytoid dendritic cells (pDCs) in immune suppression and treatment resistance in acute myeloid leukemia. The award will fund a 3-year research project from September 2024 through August 2027 to advance the scientific understanding of how pDCs...
The Department of the Army Medical Command awarded a $1,437,602 Project Grant to The Trustees of Columbia University in New York, NY under the Military Medical Research and Development program (CFDA 12.420). The three-year award will support development of novel gene and RNA therapies to prevent and restore noise-induced hearing loss. Specifically, researchers will develop long-term gene therapy and short-term siRNA products targeting the NOX3 pathway and validate efficacy and safety in auditory...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $402,500.00 to Case Western Reserve University to research repurposing an FDA-approved drug to mitigate noise-induced hearing loss. The award period runs from May 1, 2025 to April 30, 2027. As a leading private research university, Case Western Reserve University has a robust history of supporting federal agencies through biomedical research, engineering, and...